Bayer will shut down its 60-year-old plant in Türkiye by the end of 2027, the company has confirmed, citing cost pressures it can no longer absorb at the aging facility.

The closure ends six decades of continuous operation at a site that has served as one of Bayer's longest-running manufacturing locations in the region. For Turkish growers and regional distributors, the decision removes a familiar link in the supply chain for crop protection products, and it signals that even multinational input makers are re-evaluating production footprints as energy, labor and logistics costs climb.

Bayer framed the decision as a response to structural cost pressures rather than a withdrawal from the Turkish market. The company gave the end of 2027 as the shutdown horizon, a timeline that leaves roughly three years for wind-down operations, inventory management and workforce transition at the site.

The economics behind the move reflect pressures now common across the agricultural input sector. Older single-site plants carry higher unit costs than newer, larger, integrated facilities. When energy prices spike and regulatory compliance demands capital investment, manufacturers face a choice: modernize aging assets or consolidate production elsewhere. Bayer has chosen consolidation, a path several input makers have taken as they rationalize global capacity.

For Turkish farmers, the near-term question is supply continuity. A plant closure does not by itself remove products from the market, but it can shift sourcing to imports or other regional facilities, with implications for delivery times, pricing and distribution arrangements. Distributors and cooperatives that have drawn product from the site will need clarity on which facilities will serve the Turkish market after 2027.

The closure also carries weight for the local labor market. A 60-year-old plant typically anchors a workforce and a supplier network built over generations. Bayer's three-year runway until end-2027 gives the company and local authorities time to manage that transition, though the source material did not specify headcount at the facility or details of any severance arrangements.

The decision fits a broader pattern of cost-driven restructuring among global ag input manufacturers. Companies across the crop protection and seed sectors have been closing or consolidating older sites to protect margins as farm incomes tighten and growers push back on input prices. Türkiye, with its large but cost-sensitive agricultural base, sits squarely in that tension: farmers demand affordable inputs, while manufacturers face rising production costs.

Bayer has not detailed in the available reporting where production currently handled at the Turkish plant will shift, nor what investment, if any, will accompany the reallocation. Those specifics will matter for Turkish distributors planning inventories beyond 2027 and for competitors evaluating whether to fill any gap in local supply.

The company's stated timeline, end-2027, now stands as the key date to watch. Until then, the plant continues operating, and Bayer's Turkish customers will be looking for confirmation that product availability and pricing will hold steady through the transition.